# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Barclays analyst Balaji Prasad maintains Alvotech (NASDAQ:ALVO) with a Overweight and raises the price target from $20 to $22.
Alvotech tightened guidance for EBIDTA to $100 - $150 million for the full year.
Alvotech (NASDAQ:ALVO) reported quarterly losses of $(0.89) per share. This is a 28.23 percent increase over losses of $(1.24) ...
It’s a rather quiet session on Tuesday, with major U.S. averages trading around the flatline at midday trading in New York.